pubmed.ncbi.nlm.nih.gov

Current status and reflections on fertility preservation in China - PubMed

Review

Current status and reflections on fertility preservation in China

Jiakai Zhang et al. J Assist Reprod Genet. 2022 Dec.

Abstract

Purpose: With the progress of medical technology and renovated conception of fertility, the prospective studies and practice of fertility preservation are drawing more and more attention from medical workers. With the largest population of over 1.4 billion, China makes the experience accumulated in fertility preservation efforts even more relevant. This article summarizes China's experience and shares it with the world to promote the healthy development of fertility preservation.

Methods: This study was based on multiple Chinese expert consensuses on fertility preservation issued in 2021 and the current national regulations and principles, compared with the latest advice and guidelines issued by global reproductive authorities such as the ASRM and ESHRE. Summarize the experience and reflection of Chinese scholars in the process of fertility preservation.

Results: This study reports on the current situation of fertility preservation in China, sharing the Chinese experience gained in the process of development, and offering Chinese reflections on worrying issues.

Conclusion: Fertility preservation is a medical and social issue of reproductive health security, which is conducive to the sound development of the world population and social production.

Keywords: Application scope; China; Compassionate preservation; Fertility preservation; Posthumous-assisted reproduction; Reproductive ethics.

© 2022. The Author(s).

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1

Statistics on the number and regional distribution of ART medical institutions in mainland China

Fig. 2
Fig. 2

Statistics on the number of oocyte retrieval cycles in mainland China

Fig. 3
Fig. 3

Statistical data of human sperm bank in mainland China from 2010 to 2020

Fig. 4
Fig. 4

Gametes/embryos/tissues that can be used for fertility preservation

Fig. 5
Fig. 5

Various stem cells that can be induced to produce sperm. Spermatagonial stem cells, SSCs; mesenchymal stromal cells, MSCs; embryonic stem cells, ESCs; induced pluripotent stem cells, iPSCs; primordial germ cells, PGCs

Similar articles

Cited by

References

    1. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24(18):2917–2931. doi: 10.1200/JCO.2006.06.5888. - DOI - PubMed
    1. Reproductive Medicine Branch of Chinese Medical Association. 生育力保存中国专家共识 [Chinese Expert Consensus on Fertility Preservation]. 生殖医学杂志, 2021;30(9), 1129–1134. 10.3969/j.issn.1004-3845.2021.09.002.
    1. Chinese Male Fertility Preservation Consensus Writing Committee. 中国男性生育力保存专家共识 [Chinese Consensus on Male Fertility Preservation]. 中华生殖与避孕杂志, (2021);41(3), 191–198. 10.3760/cma.j.cn101441-20200831-00469.
    1. Fertility Preservation Committee of Chinese Maternal and Child Association. 女性生育力保存临床实践中国专家共识 [Chinese Expert Consensus on Clinical Practice of Female Fertility Preservation]. 中华生殖与避孕杂志, (2021);41(5), 383–391. 10.3760/cma.j.cn101441-20210228-00092.
    1. China National Bureau of Statistics. 中国统计年鉴 [China Statistical Yearbook]. China Statistics Press, 2021.

Publication types

MeSH terms

LinkOut - more resources